CeriBell (CBLL) Competitors $26.62 -0.10 (-0.37%) (As of 11:56 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends CBLL vs. AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, CNMD, and TNDMShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), CONMED (CNMD), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. CeriBell vs. Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker CONMED Tandem Diabetes Care CeriBell (NASDAQ:CBLL) and Axonics (NASDAQ:AXNX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment. Which has better earnings and valuation, CBLL or AXNX? CeriBell has higher earnings, but lower revenue than Axonics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$60.04M15.94N/AN/AN/AAxonics$366.38M9.90-$6.09M-$0.12-591.45 Is CBLL or AXNX more profitable? CeriBell has a net margin of 0.00% compared to Axonics' net margin of -1.31%. Axonics' return on equity of 0.36% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Axonics -1.31%0.36%0.31% Does the MarketBeat Community believe in CBLL or AXNX? Axonics received 166 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 66.41% of users gave Axonics an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes8100.00% Underperform VotesNo VotesAxonicsOutperform Votes17466.41% Underperform Votes8833.59% Do institutionals & insiders have more ownership in CBLL or AXNX? 99.5% of Axonics shares are held by institutional investors. 1.9% of Axonics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor CBLL or AXNX? In the previous week, CeriBell had 1 more articles in the media than Axonics. MarketBeat recorded 1 mentions for CeriBell and 0 mentions for Axonics. CeriBell's average media sentiment score of 0.00 equaled Axonics'average media sentiment score. Company Overall Sentiment CeriBell Neutral Axonics Neutral Do analysts recommend CBLL or AXNX? CeriBell presently has a consensus target price of $32.60, indicating a potential upside of 22.01%. Axonics has a consensus target price of $71.00, indicating a potential upside of 0.03%. Given CeriBell's stronger consensus rating and higher possible upside, equities research analysts plainly believe CeriBell is more favorable than Axonics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Axonics 0 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryCeriBell beats Axonics on 7 of the 13 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$957.22M$3.14B$5.20B$9.14BDividend YieldN/A1.77%5.12%4.28%P/E RatioN/A17.1586.9017.13Price / Sales15.9452.731,138.53122.82Price / CashN/A39.9343.2337.84Price / BookN/A3.794.804.78Net IncomeN/A$89.83M$120.46M$225.43M7 Day Performance-2.59%0.85%-0.94%-0.82%1 Month Performance1.56%-0.91%14.81%1.02%1 Year PerformanceN/A0.96%29.53%15.72% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBellN/A$26.62-0.4%$32.60+22.5%N/A$953.64M$60.04M0.00N/ANews CoverageAXNXAxonics1.4367 of 5 stars$70.98+0.8%$71.00+0.0%+13.5%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.187 of 5 stars$33.02-1.2%$32.67-1.1%+129.2%$3.57B$577.74M-23.861,453NVSTEnvista3.5083 of 5 stars$19.58+0.6%$20.65+5.5%-22.3%$3.37B$2.50B-2.5112,800NARIInari Medical3.3326 of 5 stars$56.26+1.2%$58.89+4.7%-19.0%$3.29B$574.50M-41.181,300IRTCiRhythm Technologies2.921 of 5 stars$89.89+4.0%$107.82+19.9%-17.2%$2.81B$492.68M-17.782,000LIVNLivaNova3.4854 of 5 stars$50.22-2.5%$69.17+37.7%-9.3%$2.73B$1.24B122.622,900ENOVEnovis3.0152 of 5 stars$46.56+0.9%$67.00+43.9%-24.3%$2.60B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5906 of 5 stars$24.35+3.0%$20.73-14.9%+85.4%$2.48B$669.77M-87.523,491CNMDCONMED4.6326 of 5 stars$71.99-0.8%$79.80+10.8%-38.7%$2.22B$1.29B17.234,000Positive NewsTNDMTandem Diabetes Care4.713 of 5 stars$33.50+2.6%$53.81+60.6%+24.1%$2.20B$747.72M-16.922,400Positive News Related Companies and Tools Related Companies Axonics Alternatives NovoCure Alternatives Envista Alternatives Inari Medical Alternatives iRhythm Technologies Alternatives LivaNova Alternatives Enovis Alternatives Warby Parker Alternatives CONMED Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBLL) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBLL Stock Alerts